Skip to site menu Skip to page content

Daily Newsletter

17 October 2023

Daily Newsletter

17 October 2023

Philips unveils monitoring tool to simplify patient data in ORs

Visual Patient Avatar addresses this issue by using animations, colours, and shapes to represent vital information.

October 16 2023

Top of FormRoyal Philips has unveiled a monitoring solution called Visual Patient Avatar, which simplifies complex patient data into a user-friendly visual format.

In operating rooms, information overload and time constraints are said to often lead to poor situational awareness, causing anaesthesia-related errors.

Visual Patient Avatar addresses this issue by using animations, colours, and shapes to represent vital information, making it easier for anaesthesiologists and nurse anaesthetists to understand and process critical data.

This solution was developed in collaboration with clinicians at the Visualisation Technology Research Group at the Institute of Anaesthesiology, University Hospital of Zürich.

The idea for Visual Patient Avatar is claimed to have been inspired from the clear, visual representations found on airplane flight dashboards.

This solution aims to reduce human errors in the operating room by presenting information in a clear, logical manner that is easy to comprehend.

Philips stated that the development of Visual Patient Avatar involved validation and refinement through studies with more than 150 clinicians in Swiss hospitals.

The results showed that it improved the recall of vital signs, increased the perception of vital signs, and reduced the perceived workload.

During the first use of Visual Patient Avatar, 73% of vital sign information was correctly identified.

Philips hospital patient monitoring general manager Christoph Pedain said: “Created by anaesthesiologists for anaesthesiologists and nurse anaesthetists, the intentionally simple design of Visual Patient Avatar is having a profound impact on clinical confidence and addressing cognitive overload.

“By helping clinical care teams make timely decisions without losing their cognitive focus, they can prepare for what may come next – improving patient outcomes and saving lives.”

AI will become a key driver of medical device innovation

With only a few approved drugs currently available to treat DN by means other than regulation of blood pressure, innovator products that can treat by targeting other factors such as treatment of dyslipidemia, hypertension, or angiotensin inhibition, among others, is a key area of R&D in the DN space and is likely to pave the way for novel therapies in the near future. However, the treatment landscape is expected to remain unchanged due to limited availability of products in the late-stage pipeline currently.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close